Hancock Jaffe Hancock Jaffe
  • Home
  • About
    • Our History
    • Senior Management
    • Board Of Directors
    • Medical Advisory Board Members
  • Products
    • The VenoValve®
    • CoreoGraft® – Bypass Graft
  • Contact
  • Careers
  • Investors
    • Overview
    • Investor Presentation
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    • Proxy Information
Hancock Jaffe Hancock Jaffe
  • Home
  • About
    • Our History
    • Senior Management
    • Board Of Directors
    • Medical Advisory Board Members
  • Products
    • The VenoValve™
    • CoreoGraft™ – Bypass Graft
  • Contact
  • Careers
  • Investors
    • Overview
    • Investor Presentation
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • Analyst Coverage
    • SEC Filings
    • Corporate Governance
    • Proxy Information

Press Releases

Investors
  • Overview
  • Investor Presentation
  • News / Events
    • Recent News / Events
    • Press Releases
    • Articles & Publications
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Profile
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
  • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Proxy Information
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News / Events

  • Recent News / Events
  • Press Releases
  • Articles & Publications
  • IR Calendar
  • Email Alerts

Hancock Jaffe Concludes Successful VenoValve Pre-IDE Meeting with FDA

Jan 12, 2021

Hancock Jaffe Announces Executive Promotions

Dec 30, 2020

Hancock Jaffe Deemed Compliant With All NASDAQ Continued Listing Requirements

Dec 21, 2020

Hancock Jaffe Reports Two CoreoGraft Patients Have Reached 30 Day Milestone

Dec 16, 2020

Hancock Jaffe Announces Significant Improvements in all Study Endpoints For Final VenoValve First-in-Human Data

Dec 15, 2020

Hancock Jaffe Announces One Year Follow-up Data on Eleventh VenoValve Patient

Dec 14, 2020

Hancock Jaffe to Provide VenoValve and CoreoGraft Updates at Ladenburg Thalmann R&D Showcase Webinar on December 16, 2020

Dec 10, 2020

Hancock Jaffe Announces One Year Follow-up Data on Tenth VenoValve Patient

Dec 1, 2020

Hancock Jaffe Announces Reverse Stock Split

Nov 27, 2020

Hancock Jaffe's VenoValve(R) Results Featured in Journal of Vascular Surgery Venous and Lymphatic Disorders

Nov 23, 2020
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
Copyright© 2021 by Hancock Jaffe Laboratories, Inc. All Rights Reserved | Terms of Use & Privacy Policy | Designed by Velocidi
Show / Refresh / Reset / Delete
Views until show: 5
Seconds until show: 5
By using this website, you consent to the use of cookies, as described in our privacy policy.Accept